Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -92.93% is 48% above its 5-year average of -180.14%, near the high end of its 5-year range (-652.78%–-70.99%).
As of the fiscal period ended Tuesday, June 30, 2026. 70.30% above its 12-month average of -312.87%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -92.93%.
RETURN ON INVESTED CAPITAL (ROIC)
-92.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-312.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-214.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-180.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-234.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+70.30%
CURRENT VS 3Y AVG
+56.77%
CURRENT VS 5Y AVG
+48.41%
CURRENT VS 10Y AVG
+60.31%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 709 covered companies
CURRENT VS SECTOR MEDIAN
-175.51%
vs the sector median at left
ENDRA Life Sciences Inc.
Market Cap
$7.96M
Return on Invested Capital (ROIC)
-92.93%
TTM Avg
-312.87%
3Y Avg
-214.95%
5Y Avg
-180.14%
Market Cap
$7.93M
Return on Invested Capital (ROIC)
-457.75%
TTM Avg
-214.65%
3Y Avg
-192.14%
5Y Avg
-209.63%
Market Cap
$8.11M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-174.21%
3Y Avg
-638.36%
5Y Avg
-516.05%
Market Cap
$8.12M
Return on Invested Capital (ROIC)
-33.73%
TTM Avg
-84.97%
3Y Avg
-168.83%
5Y Avg
-136.52%
Market Cap
$7.62M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-63.63%
3Y Avg
-49.78%
5Y Avg
-53.46%
Market Cap
$8.25M
Return on Invested Capital (ROIC)
-439.90%
TTM Avg
-355.30%
3Y Avg
-355.30%
5Y Avg
-355.30%
Market Cap
$8.48M
Return on Invested Capital (ROIC)
-21.90%
TTM Avg
-47.33%
3Y Avg
-176.82%
5Y Avg
-106.87%
Market Cap
$7.37M
Return on Invested Capital (ROIC)
-92.94%
TTM Avg
-279.36%
3Y Avg
-244.50%
5Y Avg
-201.18%
Market Cap
$7.33M
Return on Invested Capital (ROIC)
-211.58%
TTM Avg
-206.45%
3Y Avg
-187.44%
5Y Avg
-143.49%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | $7.96M | -92.93% | -312.87% | -214.95% | -180.14% |
| GT Biopharma, Inc. (GTBP)vs › | $7.93M | -457.75% | -214.65% | -192.14% | -209.63% |
| HeartSciences Inc. (HSCS)vs › | $8.11M | N/A | -174.21% | -638.36% | -516.05% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.12M | -33.73% | -84.97% | -168.83% | -136.52% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | -107.08% | -63.63% | -49.78% | -53.46% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.25M | -439.90% | -355.30% | -355.30% | -355.30% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.48M | -21.90% | -47.33% | -176.82% | -106.87% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.37M | -92.94% | -279.36% | -244.50% | -201.18% |
| Longeveron Inc. (LGVN)vs › | $7.33M | -211.58% | -206.45% | -187.44% | -143.49% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -995.44% | -481.38% | -268.85% | -219.77% |
ROIC
-92.9%
ROE
-93.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -92.93% |
| 2026-03-31 | -248.49% |
| 2025-12-31 | -185.74% |
| 2025-09-30 | -652.78% |
| 2025-06-30 | -384.40% |
| 2025-03-31 | -364.94% |
| 2024-12-31 | -269.29% |
| 2024-09-30 | -102.64% |
| 2024-06-30 | -102.54% |
| 2024-03-31 | -263.33% |
| 2023-12-31 | -178.94% |
| 2023-09-30 | -218.02% |
| 2023-06-30 | -168.17% |
| 2023-03-31 | -272.93% |
| 2022-12-31 | -173.15% |
| 2022-09-30 | -118.80% |
| 2022-06-30 | -87.94% |
| 2022-03-31 | -122.58% |
| 2021-12-31 | -100.44% |
| 2021-09-30 | -76.61% |
| 2021-06-30 | -70.99% |
| 2021-03-31 | -60.54% |
| 2020-12-31 | -146.29% |
| 2020-09-30 | -312.38% |
| 2020-06-30 | -607.35% |
| 2020-03-31 | -387.95% |
| 2019-12-31 | -199.86% |
| 2019-09-30 | -413.14% |
| 2019-06-30 | -516.94% |
| 2019-03-31 | -234.86% |
| 2018-12-31 | -144.35% |
| 2018-09-30 | -4165.35% |
| 2018-06-30 | -342.95% |
| 2018-03-31 | -250.96% |
| 2017-12-31 | -87.67% |
| 2017-09-30 | -36.91% |
| 2017-06-30 | -30.06% |
| 2016-12-31 | -3184.11% |
| 2016-09-30 | -520.29% |
| 2016-06-30 | -350.18% |
| 2015-12-31 | -536.04% |
